Cellectar Biosciences (CLRB) Q2 2026 Earnings

14MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-4.9
-3.71
-2.52
-1.33

Details

Expected EPS
-1.885
Actual EPS
-1.33
Surprise EPS
0.55
Surprise Percent
+29.44%

Description

Cellectar Biosciences (CLRB) has reported earnings of -1.33 per share for Q2 2026.

0 Comments

Share your thoughts